Attached files
| file | filename |
|---|---|
| 8-K - 8-K - Armata Pharmaceuticals, Inc. | v399260_8k.htm |
Exhibit 16.1
January 22, 2015
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Commissioners:
We have read AmpliPhi Biosciences Corporation’s statements included under Item 4.01 of its Form 8-K filed on January 22, 2015 and we agree with such statements concerning our firm.
/s/ PBMares, LLP
PBMares, LLP